A Leading European Cannabis Company
Franchise Cannabis is a global, fully integrated, seed-to-sale medical cannabis company with a diverse portfolio of cultivation, processing and distribution operations in Germany, Denmark, Uruguay, and Colombia. We are internationally focused with vertically integrated operations servicing the high value European Medical Market underpinned by leading low cost production in the Latin American region.
We are addressing the European product deficit and shortage of GMP grade medicinal cannabis by developing cultivation assets within Europe. It is projected that Europe will become the world’s largest legal cannabis market in next 5 years.
Leading Distribution PlatformLearn more
Franchise acquired a 100% interest in ACA Müller ADAG Pharma, a licensed medical cannabis distributor in Germany since 2017. Our distribution facility currently serves a network of 950 pharmacies with imports from another medical cannabis cultivator within the EU.
Indoor Cultivation for EU MarketLearn more
Franchise is fully licensed for THC cultivation with a 4,000+ ft² indoor facility fully built out in Randers, Denmark with a planned Phase 2 expansion of 80,000 ft². Our Denmark division is positioned to be one of the first companies to export medicinal cannabis flower throughout the European market after achieving EU-GMP certification.
Outdoor THC & CBD CultivationLearn more
Colombia will serve to be Franchise’s low-cost operations to drive exports. We are fully licensed to cultivate THC & CBD cannabis and its derivatives.
Outdoor Hemp CultivationLearn more
Franchise possesses all licenses to cultivate, process, sell, import and export <1% THC cannabis. Uruguay is more advantageous than other regions for industrial hemp cultivation due to the higher allowance of THC content (USA, Canada <0.3% and in Europe <0.2%).
Genetics BankLearn more
Franchise acquired Harmony Health, a world-class seeds and genetics company, in 2018. Harmony Health possesses over 240 strains in its seed bank, many of which are rare land races and parent stock. We are constantly innovating to address market trends by breeding new cannabis varieties for an assortment of applications including medical, high CBD profiles, and flower yields.
Headed by a highly experienced management team with a significant track record in the industry. We take pride in every step of the process starting from our soils to the final product formulation to ensure the highest quality.
Grow with us
Franchise Cannabis is a company focused on developing world class medical cannabis projects globally and distributing our production across growing markets as they open up. We have a strong growth profile over the coming quarters with growing extract product inventories in our Latin America Division as well as continued market share growth in the European markets, underpinned by our strong German presence.
September 16, 2019Franchise Cannabis’s German Subsidiary Commits to Purchase of Medical Cannabis from MJardin’s Halifax Facility
July 21, 2019Franchise Cannabis Reports a Surge in Patient Growth at German Subsidiary and Increased Supply from the Netherlands
June 7, 2019Franchise Cannabis Announces Reverse Takeover Transaction and Concurrent Subscription Receipt Financing
Get in touch with us by completing the inquiry form.